Pipeline
Leadership
- Management Team
- Board of Directors
Medical Affairs
News & Investors
Careers
Contact

Pipeline
Leadership
Medical Affairs
News & Investors
Careers
Contact

Management Team
Board of Directors

MEDINFO
Adverse Event
Product Quality Complaint
Research Focus
Clinical Trials
CME Grant
Investigator Initiated Study
Find your field medical director

Atopic Dermatitis
Psoriasis

RVT-502

RVT-502

December 3, 2019

Dermavant Announces First Patient Dosed in Phase 2 ...

Read More

December 6, 2018

Dermavant Sciences to Present New Data on Cerdulat ...

Read More

Recent Posts

Dermavant to Present Data from Multiple Studies of VTAMA<sup>®</sup> (tapinarof) cream, 1% at the 2023 Winter Clinical Dermatology Conference
Dermavant Launches First Commercial for VTAMA<sup>®</sup> (tapinarof) cream, 1% as Part of a National, Multimedia Campaign for Adults with Plaque Psoriasis
Dermavant Announces Highly Favorable Results from Pediatric Maximal Usage Study of VTAMA<sup>®</sup> (tapinarof) cream, 1% in Atopic Dermatitis
Dermavant to Present Data from Multiple Clinical Trials of VTAMA® (tapinarof) cream, 1% at the 2022 Fall Clinical Dermatology Conference
Fortune and Great Place to Work<sup>®</sup> Name Dermavant One of the Best Small Workplaces<sup>™</sup> and Best Workplaces in Biopharma<sup>™</sup> in 2022

Archives

Categories

Dermavant Sciences
News
RVT-201
RVT-501
RVT-502
RVT-504
Tapinarof

Find Us

Dermavant Sciences, Inc.
3780 Kilroy Airport Way
Suite 250
Long Beach, CA 90806
United States

Company
Medical Information
Compliance Program

Leadership
Careers
Contact
News & Investors

Pipeline
MEDINFO
Clinical Trials
Research Focus
CME Grant

Management Team
Board of Directors

Atopic Dermatitis
Psoriasis

Company
- Leadership
  - Management Team
  - Board of Directors
- Careers
- Contact
- News & Investors
Medical Information
- Pipeline
- MEDINFO
- Clinical Trials
- Research Focus
  - Atopic Dermatitis
  - Psoriasis
- CME Grant
Compliance Program

Copyright © 2023 Dermavant Sciences, Inc. All Rights Reserved. All trademarks are the property of Dermavant Sciences, GmbH.
Privacy Policy | Terms of Use | Terms of Sale – Independent Pharmacies | Terms of Sale – Wholesalers | US Wholesalers